Article
Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy.
Biochemical and biophysical research communications - 8 Jun 2007
Yang Peixin, Zhao Zhiyong, Reece E Albert
Abstract excerpt
The mechanisms for diabetic embryopathy are not well understood. JNK1/2 activation is increased in diabetic embryopathy, and antioxidants abolish JNK activation, and thus, ameliorate diabetic embryopathy. Phosphorylated SEK1 were significantly elevated in malformed embryos from diabetic mouse. In a dose-dependent manner, JNK inhibitor (SP600125) significantly reduced hyperglycemia-induced embryopathy....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
